
SoftBank, the Japanese tech giant, has announced a joint venture (JV) with Tempus, a Chicago-based healthcare technology company, to establish a foothold in the AI-powered healthcare sector in Japan. This venture, named SB Tempus, aims to leverage artificial intelligence (AI) to analyze personal medical data to provide personalized treatment recommendations.
ソフトバンクグループ、Tempusとともに医療データとAIの活用により日本の医療のさらなる進歩に貢献するジョイントベンチャー「SB TEMPUS」を設立https://t.co/jtSgTfW4pi#ソフトバンクグループ #SoftBankGroup
— SoftBank Group Corp. (@SoftBank_Group) June 27, 2024
The news comes on the heels of SoftBank’s $200 million investment in Tempus earlier this year, just before Tempus’s initial public offering (IPO). This partnership signifies a strategic move by SoftBank to expand its presence in AI, an area of continued focus for the company, while Tempus gains access to the vast Japanese healthcare market.

